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Purpose: Itopride hydrochloride (itopride) inhibits acetyl-
cholinesterase (AChE) and antagonizes dopamine D2 receptor, 
and has been used as a gastroprokinetic agent. However, its 
prokinetic effect on the small bowel or colon has not yet been 
thoroughly investigated. The aim of this study was to 
investigate the effects of itopride on motor functions of the 
ileum and colon in guinea pigs. Materials and Methods: The 
distal ileum was excised and the activity of peristaltic 
contraction was determined by measuring the amplitude and 
propagation velocity of peristaltic contraction. The distal colon 
was removed and connected to the chamber containing 
Krebs-Henseleit solution (K-H solution). Artificial fecal matter 
was inserted into the oral side of the lumen, and moved toward 
the anal side by intraluminal perfusion via peristaltic pump. 
Colonic transit times were measured by the time required for 
the artificial feces to move a total length of 10 cm with 2-cm  
intervals. Results: In the ileum, itopride accelerated peristaltic 
velocity at higher dosage (10-10-10-6 M) whereas neostigmine 
accelerated it only with a lower dosage (10-10-10-9 M). 
Dopamine (10-8 M) decelerated the velocity that was recovered 
by itopride infusion. Itopride and neostigmine significantly 
shortened colonic transit at a higher dosage (10-10-10-6 M). 
Dopamine (10-8 M) delayed colonic transit time that was also 
recovered after infusion of itopride.  Conclusion: Itopride has 
prokinetic effects on both the ileum and colon, which are 
regulated through inhibitory effects on AChE and antagonistic 
effects on dopamine D2 receptor.
Key Words: Itopride, acetylcholinesterase inhibitor, dopamine 
D2 receptor antagonist
INTRODUCTION
Gastrointestinal motility is regulated by the 
enteric nervous system, which is part of the 
autonomic nervous system, as well as humoral 
substances.1 Acetylcholine (ACh) from the para-
sympathetic nerve has an excitatory effect on 
ileocolonic motility. On the other hand, 
norepinephrine inhibits the release of AChE from 
motor neurons, resulting in smooth muscle 
relaxation.2 Dopamine has also been confirmed as 
1 of the enteric neurotransmitters.3 The 2 classical 
population of dopamine receptors, D1 and D2, are 
present in the gut. D1 receptors are located mainly 
on post-junctional effector cells whereas D2 
receptors are located on both post- and pre- 
junctional cells. The pre-junctional D2 receptor 
exerts a negative modulatory effect on the release 
of ACh from the intrinsic cholinergic nerve 
terminal.4,5
Itopride has a benzamide structure and has 
been known to be a gastroprokinetic agent.6 
Itopride stimulates the release of endogenous 
acetylcholine release by antagonizing dopamine 
D2 receptor on post-synaptic cholinergic neurons, 
and also has an anticholinesterase activity, making 
ACh accumulate at cholinergic receptor sites.7
Itopride has been known to improve symptoms 
in patients with functional dyspepsia, characterized 
by early satiety, postprandial fullness, bloating, 
and nausea.8,9 Several studies reported that 
itopride enhances gastric emptying in dogs, rats, 
and humans,10 therefore itopride may be useful 
for the treatment of functional gastrointestinal 
disorders. However, the effect of itopride on the 
small bowel or colonic motility has not been 
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clearly investigated. Therefore, we investigated 
the effect of itopride on ileal peristalsis and 
colonic transit in guinea pigs to provide experi-
mental backgrounds for the future application to 
human functional disorders.
MATERIALS AND METHODS
Experimental animals 
Male guinea pigs of Hartley strain (Nihon SLC 
Inc., Shizuoka, Japan), weighing approximately 
300 g,were individually housed at 22 - 24℃. Guinea 
pigs were killed by blow to the occipital region in 
the head and severing the carotid arteries. The 
experimental procedures were conducted in 
accordance with the guidelines of Yonsei 
University Animal Care and Use Committee.
Drugs 
Drugs used in this study included itopride 
hydrochloride (Abbott, Katsuyama, Japan), dopa-
mine (Sigma, St. Louis, MO, USA), neostigmine 
(Sigma, St. Louis, MO, USA), and acetylcholine 
(Sigma, St. Louis, MO, USA).
Experimental apparatus
BIOPAC TSD 105 (BIOPAC System Inc., Santa 
Barbara, CA, USA) was used to estimate the 
tension of the circular muscle, and BIOPAC MP 
100 (BIOPAC System Inc., Santa Barbara, CA, 
USA) was used to analyze the data. A peristaltic 
pump (Masterflex 7523 - 30 with cartridge 3519 - 
85, Cole-Palmer, Chicago, IL, USA) was used to 
induce peristaltic contraction wave. 
Estimation of peristaltic contraction in the guinea 
pig ileum
The method designed by Tonini et al,11 
subsequently modified,12 was experimental bath 
for the estimation of peristalsis. The abdominal 
cavity was opened and the distal ileum was 
excised 15 cm from the ileocecal junction. The 
mesenteric attachment was trimmed away, 
flushed clean with K-H solution and placed 
immediately into a bath containing K-H solution. 
The solution was saturated with 95% O2 and 5% 
CO2 and maintained at 37℃. The mechanical 
activity of the circular muscle in the fixed guinea 
pig ileum was monitored using 3 small clips, 
arranged at 2.5 cm intervals. The clips were 
attached via 3 sites of the serosal surface to the 
underlying circular muscle of the ileum in the 
peristaltic chamber. These were also attached to 
independent tension transducers via thread. Initial 
tension was routinely set to 1 g. Tissues were left 
to equilibrate in K-H solution for approximately 
60 min prior to the start of the experiment. K-H 
solution was pumped (0.4 mL/min) into the 
lumen of the ileal segment for 20 min through the 
peristaltic pump to induce the peristalsis. Itopride 
(10-10-10-6 M) was added to the bath solution and 
ileal lumen for 20 min without washing between 
successive change of concentration. The activity of 
the peristaltic contraction was determined by 
amplitude and measurement of the propagation 
velocity of peristaltic contractions. The propaga-
tion velocity was measured by dividing the 
distance from the oral to the anal side (5 cm) by 
the time (sec) when the first peristaltic wave 
moved from the oral to anal side.
To evaluate the mechanism of itopride’s action, 
additional experiments were performed in the 
presence of neostigmine (10-10-10-7 M), dopamine 
(10-8 M), and ACh (10-8 M) as previously described. 
Finally, itopride (10-7 M) was separately admini-
stered after dopamine (10-8 M) and ACh (10-8 M) 
infusion.
Estimation of colonic transit time in guinea pig 
colon
The colonic transit study was performed as 
previously described.13 The distal colon (approxi-
mately 10 cm from the anus) was excised, flushed 
clean with K-H solution, and immediately placed 
into the bath containing K-H solution saturated 
with 95% O2 and 5% CO2, at 37℃. Both ends of 
the colon were connected to the 2 sides (oral and 
anal) in the chamber. After stabilization for about 
60 min, artificial feces (length, 10 mm; width, 4
mm) were inserted into the oral side of the lumen, 
and K-H solution was pumped (0.4 mL/min) into 
the lumen of the colon. The artificial feces could 
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Fig. 1. The effect of itopride on amplitude of peristaltic 
contraction. Itopride (10-10-10-6 M) did not change the 
amplitude of peristaltic contraction significantly.
Fig. 2. The effect of dopamine alone and itopride plus 
dopamine on amplitude of peristaltic contraction. Dopamine
(10-8 M) or dopamine with itopride (10-7 M) did not change 
the amplitude significantly.
then be moved from the oral to the anal side of 
the colon. Total 10 cm was observed, and the time 
taken to move about 2 cm was measured. 
Immediately after the control test, itopride 
(10-10-10-6 M) was applied to the bath and the 
lumen by increasing the concentrations without 
washing between concentrations. For each sample, 
the time taken to move 2 cm was measured and 
the last 4 measurements were selected by value of 
means. Additional experiments were performed in 
the presence of neostigmine (10-10-10-7 M), dopamine 
(10-8 M), and ACh (10-8 M) as previously described. 
Finally, itopride (10-7 M) was separately admini-
stered after dopamine (10-8 M) and ACh (10-8 M) 
infusion.
Statistical analysis
The result for each variable was represented as 
a percentage of the measurements before 
administration of itopride (% change of control) 
and recorded as the mean with standard error. 
Wilcoxon signed rank test was used for statistical 
analysis, and the significance level was set at p < 
0.05.
RESULTS
Estimation of the ileal peristaltic contraction in 
guinea pig ileum
Itopride (10-10-10-6 M) infusion in guinea pig 
ileum increased the amplitude of peristaltic 
contraction, which was not statistically significant 
(Fig. 1). Dopamine (10-8 M) alone decreased but 
itopride (10-7 M) infused after dopamine increased 
the amplitude, however, with no statistical signi-
ficance (Fig. 2). Additional itopride (10-7 M) added 
to ACh (10-8 M) further increased the amplitude, 
but with no statistical significance (Fig. 3).
Itopride (10-10-10-6 M) significantly accelerated 
the propagation velocity of the peristalsis (Fig. 4) 
(p < 0.05). Dopamine (10-8 M) decelerated the 
propagation velocity to 81.3 ± 5.4%, but itopride 
(10-7 M) overcame the velocity up to 109.3 ± 3.86% 
(Fig. 5) (p < 0.05). Neostigmine at a lower con-
centration (10-10-10-9 M), significantly accelerated 
the velocity, but it decreased at a higher 
concentration (10-8-10-7 M) (Fig. 6) (p < 0.05). 
Estimation of colonic transit time 
Itopride (10-10-10-6 M) significantly dose-depen-
dently shortened colonic transit time compared 
with the control (Fig. 7) (p < 0.05). Neostigmine 
(10-10-10-7 M) shortened colonic transit time 
compared with the control, but was statistically 
significant only at a higher concentration (10-8-10-7 
M) (Fig. 8) (p < 0.05). 
Dopamine (10-8 M) delayed colonic transit time 
up to 114.6 ± 9.3%. When itopride (10-7 M) was
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Fig. 3. Itopride (10-7 M) added to ACh (10-8 M) further 
increased the amplitude with no statistical significance.
Fig. 4. The effect of itopride on the propagation velocity
of the peristaltic contraction. Itopride (10-10-10-6 M) signifi-
cantly accelerated the velocity dose-dependently (*p < 
0.05). 
Fig. 5. The effect of dopamine alone and dopamine plus 
itopride on the propagation velocity of the peristaltic 
contraction. Dopamine (10-8 M) significantly decelerated 
the propagation velocity of the peristaltic contraction to 
81.3 ± 5.4% (*p < 0.05). When itopride (10-7 M) was admini-
stered in the presence of dopamine, the velocity was 
increased up to 109 ± 3.86% with statistical significance (†p 
< 0.05).
Fig. 6. The effect of neostgmine on the propagation 
velocity of peristaltic contraction. Neostigmine at lower 
concentration significantly increased the velocity, but 
decreased at higher concentrations (*p < 0.05).
administered, transit time was shortened to 80.1 
± 9.0% (Fig. 9) (p < 0.05). ACh shortened colonic 
transit time as we expected, but itoprid with ACh 
did not have additive effect (Fig. 10).
 
DISCUSSION
Itopride is an AChE inhibitor as well as 
dopamine D2 receptor antagonist.6,7 It has been 
known to enhance gastric motility and is used as 
a treatment for functional dyspepsia.8 Since the M3 
muscarinic receptor exists on the smooth muscle 
layer throughout the whole gut and ACh released 
from the enteric nerve endings stimulates the 
contraction of smooth muscle, we believe that 
itopride has a prokinetic effect on the lower 
gastrointestinal tract. Indeed, we found that 
itopride accelerated the velocity of peristaltic 
contraction of the ileum as well as shortened 
colonic transit time of guinea pig in vitro. 
In early studies, itopride had been known to 
stimulate only the upper gut.7 Itopride signifi-
cantly increased the contractile force of only the 
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Fig. 7. The effect of itopride on the colonic transit time. 
Itopride (10-10-10-6 M) dose-dependently shortened colonic 
transit time (*p < 0.05).
Fig. 8. The effect of neostigmine on colonic transit time.
Neostigmine (10-10-10-7 M) dose-dependently shortened
colonic transit time (*p < 0.05).
Fig. 9. The effect of dopamine and dopamine plus itopride
on colonic transit time. Dopamine (10-8 M) delayed colonic
transit time up to 114.6 ± 9.3%. When itopride (10-7 M) was
administered in the presence of dopamine, transit time 
was shortened to 80.1 ± 9.0% (†p < 0.05).
Fig 10. ACh shortened colonic transit time but itopride 
together with ACh did not have an additive effect.
gastric antrum and duodenum of conscious dogs. 
In the same study, itopride restored dopamine- 
induced inhibition of contractions in the gastric 
antrum and duodenum and the gastroduodenal 
responses to ACh were enhanced by itopride and 
neostigmine. In their following studies, the IC50 of 
itopride for guinea pig gastric AChE inhibition 
was 50 times as large as that of neostigmine.14 
Therefore these authors considered that itopride 
stimulates endogenous ACh release by blocking 
dopamine D2 receptor and accumulates endo-
genous ACh by anticholinesterase activity.
However there are a few in vitro studies to 
determine the stimulatory effect in the lower 
gut.15,16 Iwanaga et al.16 compared itopride and 
physostigmine on contractile responses to ACh 
and carbachol and reported that itopride 
increased the amplitude of longitudinal muscle 
contractions and frequency of peristalsis in an 
isolated segment in guinea pig ileum. Because 
itopride enhanced only contractions induced by 
ACh and failed to increase spontaneous or 
stimulation-induced ACh release, they concluded 
that itopride stimulates ileal activity by 
prevention of ACh hydrolysis.16 In this study, the 
increase of the amplitude was demonstrated after 
administration of itopride with ACh, in 
concordance with previous studies on the increase 
of contractility.
The action of itopride on colonic motor activity 
was compared with that of cisapride and 
mosapride. Many selective 5-HT4 receptor 
agonists, such as cisapride, mosapride, zacopride, 
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and tegaserod, have been demonstrated to have 
prokinetic effects on the colon.13,17 In the isolated 
guinea pig colon, only itopride significantly 
increased the frequency of peristaltic and 
segmental contractions in the proximal and distal 
colon without changing amplitude,15 which is 
partly consistent with our data. Colonic transit in 
guinea pigs and rats was also accelerated 
significantly by itopride but not by cisapride or 
mosapride. In conscious dogs, itopride showed 
stimulatory effect on digestive organs, ranging 
from the stomach to the colon. They thought that 
the effect of itopride on the colon is mainly due 
to anti-AChE activity because gastrointestinal 
smooth muscle is directly stimulated by ACh 
through the activation of the M3 muscarinic 
receptor. However in our study, dopamine 
decreased the propagation velocity of the ileum 
and significantly delayed the colonic transit time, 
which were counter-acted by the administration 
of itopride. It is highly likely that blocking effect 
of itopride on dopamine D2 receptor also 
modulates colonic motility. To our dismay, the 
administration of ACh after itopride did not 
exhibit a positive additive effect, and further 
investigation is needed to prove whether a 
cumulative effect indeed exists.
Similar to other studies on itopride,7,16 we 
evaluated the AChE activity of itopride on the 
ileum and colon and found that neostigmine 
accelerated the propagation velocity of the ileum 
at lower concentrations and dose-dependently 
shortened the colonic transit time. This pattern 
was similar to those obtained with itopride, except 
at higher concentrations, in the ileum. This con-
centration dependent effect is due to neostigmine's 
narrow concentration window.18 The accumula-
tion of ACh at intraganglionic synapses or 
neuromuscular junctions by neostigmine does not 
effectively facilitate coordinated peristalsis but 
inhibits peristalsis at higher concentrations.18
In conclusion, itopride has a stimulatory effect 
on the ileum and colon, and this is mediated 
through dopamine D2 receptor antagonist and 
AChE inhibitory action. These data will provide 
experimental background for the use of itopride 
to treat patients with constipation or other 
functional bowel disorders. 
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